CD133 (prominin 1) expression was described and used for isolation of CSCs from various solid tumors including glioblastoma [15], prostate [26], colon [20, 21], lung [24], pancreatic [17], and ovarian cancers [35] and melanoma [36]. This evidence concerns the gene PROM1 and ovarian cancer.